Binge-Eating Disorder

Anja Hilbert

doi:10.1016/j.psc.2018.10.011

Binge-Eating Disorder

Psychiatr Clin North Am. 2019 Mar;42(1):33-43. doi: 10.1016/j.psc.2018.10.011. Epub 2018 Dec 22.

Author

Anja Hilbert¹

Affiliation

¹ Integrated Research and Treatment Center AdiposityDiseases, Department of Medical Psychology and Medical Sociology, Department of Psychosomatic Medicine and Psychotherapy, University of Leipzig Medical Center, Philipp-Rosenthal-Strasse 27, Leipzig 04103, Germany. Electronic address: anja.hilbert@medizin.uni-leipzig.de.

PMID: 30704638
DOI: 10.1016/j.psc.2018.10.011

Abstract

Binge-eating disorder (BED), first included as a diagnostic entity in the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition, is characterized by recurrent episodes of binge eating without regular compensatory behaviors to prevent weight gain. With a complex multifactorial etiology, BED is the most frequent eating disorder co-occuring with significant psychopathology, mental and physical comorbidity, obesity, and life impairment. Despite its significance, BED is not sufficiently diagnosed or treated. Evidence-based treatments for BED include psychotherapy and structured self-help treatment, with cognitive-behavioral therapy as most well-established approach, and pharmacotherapy with lisdexamfetamine as FDA approved medication with a limitation of use.

Keywords: Binge eating; Diagnosis; Eating disorder; Obesity; Treatment.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antidepressive Agents, Second-Generation / therapeutic use*
Binge-Eating Disorder / diagnosis*
Binge-Eating Disorder / drug therapy
Binge-Eating Disorder / etiology
Binge-Eating Disorder / therapy*
Central Nervous System Stimulants / therapeutic use*
Humans
Psychotherapy / methods*
Weight Loss*

Substances

Antidepressive Agents, Second-Generation
Central Nervous System Stimulants